Literature DB >> 17925492

Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.

Ian S Hitchcock1, Norma E Fox, Nicolas Prévost, Katherine Sear, Sanford J Shattil, Kenneth Kaushansky.   

Abstract

Focal adhesion kinase (FAK) plays a key role in mediating signaling downstream of integrins and growth factor receptors. In this study, we determined the roles of FAK in vivo by generating a megakaryocyte lineage-specific FAK-null mouse (Pf4-Cre/FAK-floxed). Megakaryocyte and platelet FAK expression was ablated in Pf4-Cre/FAK-floxed mice without affecting expression of the FAK homologue PYK2, although PYK2 phosphorylation was increased in FAK-/- megakaryocytes in response to fibrinogen. Megakaryopoiesis is greatly enhanced in Pf4-Cre/FAK-floxed mice, with significant increases in megakaryocytic progenitors (CFU-MK), mature megakaryocytes, megakaryocyte ploidy, and moderate increases in resting platelet number and platelet recovery following a thrombocytopenic stress. Thrombopoietin (Tpo)-mediated activation of Lyn kinase, a negative regulator of megakaryopoiesis, is severely attenuated in FAK-null megakaryocytes compared with wild-type controls. In contrast, Tpo-mediated activation of positive megakaryopoiesis regulators such as ERK1/2 and AKT is increased in FAK-null megakaryocytes, providing a plausible explanation for the observed increases in megakaryopoiesis in these mice. In Pf4-Cre/FAK-floxed mice, rebleeding times are significantly increased, and FAK-null platelets exhibit diminished spreading on immobilized fibrinogen. These studies establish clear roles for FAK in megakaryocyte growth and platelet function, setting the stage for manipulation of this component of the Tpo signaling apparatus for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925492      PMCID: PMC2200856          DOI: 10.1182/blood-2007-05-089680

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.

Authors:  J Yang; J Wu; M A Kowalska; A Dalvi; N Prevost; P J O'Brien; D Manning; M Poncz; I Lucki; J A Blendy; L F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  FERM domain interaction promotes FAK signaling.

Authors:  Jill M Dunty; Veronica Gabarra-Niecko; Michelle L King; Derek F J Ceccarelli; Michael J Eck; Michael D Schaller
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

Review 3.  RAFTK/Pyk2-mediated cellular signalling.

Authors:  H Avraham; S Y Park; K Schinkmann; S Avraham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

4.  Expression of DFak56, a Drosophila homolog of vertebrate focal adhesion kinase, supports a role in cell migration in vivo.

Authors:  G L Fox; I Rebay; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  FAK integrates growth-factor and integrin signals to promote cell migration.

Authors:  D J Sieg; C R Hauck; D Ilic; C K Klingbeil; E Schaefer; C H Damsky; D D Schlaepfer
Journal:  Nat Cell Biol       Date:  2000-05       Impact factor: 28.824

6.  The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase.

Authors:  G Izaguirre; L Aguirre; Y P Hu; H Y Lee; D D Schlaepfer; B J Aneskievich; B Haimovich
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

7.  Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation.

Authors:  S Zweegman; M A Veenhof; P C Huijgens; G J Schuurhuis; A M Dräger
Journal:  Exp Hematol       Date:  2000-04       Impact factor: 3.084

8.  Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.

Authors:  Brian J Lannutti; Jonathan G Drachman
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

9.  Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin.

Authors:  N O Carragher; B Levkau; R Ross; E W Raines
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

10.  Targeting Pyk2 to beta 1-integrin-containing focal contacts rescues fibronectin-stimulated signaling and haptotactic motility defects of focal adhesion kinase-null cells.

Authors:  C K Klingbeil; C R Hauck; D A Hsia; K C Jones; S R Reider; D D Schlaepfer
Journal:  J Cell Biol       Date:  2001-01-08       Impact factor: 10.539

View more
  45 in total

1.  Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies using Fak-deficient mice.

Authors:  M E Roh; M Cosgrove; K Gorski; I S Hitchcock
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

2.  Platelet retraction force measurements using flexible post force sensors.

Authors:  Xin M Liang; Sangyoon J Han; Jo-Anna Reems; Dayong Gao; Nathan J Sniadecki
Journal:  Lab Chip       Date:  2010-01-20       Impact factor: 6.799

3.  Focal adhesion kinase regulates pathogen-killing capability and life span of neutrophils via mediating both adhesion-dependent and -independent cellular signals.

Authors:  Anongnard Kasorn; Pilar Alcaide; Yonghui Jia; Kulandayan K Subramanian; Bara Sarraj; Yitang Li; Fabien Loison; Hidenori Hattori; Leslie E Silberstein; William F Luscinskas; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

Review 4.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

5.  JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms.

Authors:  S Leah Etheridge; Michelle E Roh; Megan E Cosgrove; Veena Sangkhae; Norma E Fox; Junmei Chen; José A López; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

6.  A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function.

Authors:  Hervé Falet; Alice Y Pollitt; Antonija Jurak Begonja; Sarah E Weber; Daniel Duerschmied; Denisa D Wagner; Steve P Watson; John H Hartwig
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

7.  Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.

Authors:  Sebastian J Saur; Veena Sangkhae; Amy E Geddis; Kenneth Kaushansky; Ian S Hitchcock
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

8.  Pyk2 mediates increased adrenergic contractile responses in arteries from DOCA-salt mice - VASOACTIVE PEPTIDE SYMPOSIUM.

Authors:  Fernanda R C Giachini; Fernando S Carneiro; Victor V Lima; Zidonia N Carneiro; Maria Helena C Carvalho; Zuleica B Fortes; R Clinton Webb; Rita C Tostes
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

9.  JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation.

Authors:  H Zhan; Y Ma; C H S Lin; K Kaushansky
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

10.  Characterization of a novel focal adhesion kinase inhibitor in human platelets.

Authors:  Matthew L Jones; Amelia J Shawe-Taylor; Christopher M Williams; Alastair W Poole
Journal:  Biochem Biophys Res Commun       Date:  2009-08-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.